Loading...
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
INTRODUCTION: Clinical remission in patients with ankylosing spondylitis (AS) has been determined using composite indices such as the AS Disease Activity Score inactive disease (ASDAS-ID), Assessment of SpondyloArthritis international Society criteria partial remission (ASAS-PR), and low Bath AS Dis...
Saved in:
| Published in: | Rheumatol Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Healthcare
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7991028/ https://ncbi.nlm.nih.gov/pubmed/33351179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-020-00269-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|